GENEVA, July 6 -- INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (ICGEB) filed a patent application (IN2025/052125) for “BROADLY NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES TO DENGUE VIRUS”. With publication no. WO/2026/139995, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/42
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....